Beasley paid $100,000 to exercise 250,000 options and Xu paid $12,000 to exercise 30,000 options.
Notably, with shares in the company last closing at 38.5 cents, the board members are essentially purchasing stock at a higher price than the market.
Farm to pharma model
THC Global operates under a farm-to-pharma pharmaceutical model, now holding all three key cannabis licences.
These being a cannabis research licence, a medicinal cannabis licence for cultivation, and two manufacture licences.
THC Global’s main facility, the Southport Manufacturing Facility is the largest pharmaceutical bio-floral extraction facility in the Southern Hemisphere.
Proactive caught up with the company last month for an update.